Premium
BCSH guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn
Author(s) -
Qureshi H.,
Massey E.,
Kirwan D.,
Davies T.,
Robson S.,
White J.,
Jones J.,
Allard S.
Publication year - 2014
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12091
Subject(s) - haemolytic disease , guideline , medicine , fetus , antibody , disease , immunology , immunoglobulin g , pregnancy , biology , pathology , genetics
H. Qureshi,1 E. Massey,2 D. Kirwan,3 T. Davies,4 S. Robson,5 J. White,6 J. Jones7 & S. Allard8 1Department of Haematology, University Hospitals of Leicester, Leicester, UK, 2NHS Blood & Transplant, Bristol, UK, 3NHS Fetal Anomaly Screening Programme, UK National Screening Committee, University of Exeter, Exeter, UK, 4NHS Blood & Transplant, Manchester, UK, 5Department of Fetal Medicine, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK, 6UKNEQAS Blood Transfusion Laboratory Practice, West Hertfordshire Trust, Hertfordshire, UK, 7Welsh Blood Service, Pontyclun, UK, and 8NHS Blood and Transplant, London, UK